Why the study?
This case report describes a patient with AF who developed embolic events across coronary, mesenteric, renal, and aortic territories within four days, despite full-dose anticoagulation and dual antiplatelet therapy.
Case Report (n=1)
No
This case illustrates that recurrent catastrophic multi-territory thromboembolism (including fatal acute mesenteric ischemia) can occur within days of an embolic myocardial infarction in a patient with atrial fibrillation and left ventricular thrombus despite full-dose anticoagulation and dual antiplatelet therapy, warranting immediate imaging and surgical assessment for new abdominal symptoms.
Answers are grounded in this paper and cite their sources.
Alerts clinicians to possible breakthrough thromboembolism despite therapy in AF with LV thrombus; leaves open optimal regimens for prospective study.
We describe a patient with atrial fibrillation (AF) in whom embolic events involved the coronary, mesenteric, renal, and aortic territories within four days, the last of them during full-dose anticoagulation and dual antiplatelet therapy. A 52-year-old woman presented in AF with ST-segment elevation myocardial infarction caused by thrombi in the proximal and distal apical segments of the left anterior descending artery, without atherosclerotic disease; revascularization was planned for a later stage. Echocardiography showed an apical left ventricular (LV) thrombus, and therapeutic low-molecular-weight heparin was started. On the fourth day after admission, despite full-dose anticoagulation and dual antiplatelet therapy, she developed abdominal pain and distension with hemodynamic instability. Computed tomography angiography showed an extensive filling defect in the superior mesenteric artery from its origin, a concurrent filling defect in the infrarenal abdominal aorta, left renal infarction, pneumatosis intestinalis, and portal venous gas. Emergency laparotomy revealed necrosis of the entire small bowel and colon with microperforations. Given the non-salvageable extent of necrosis, the abdomen was closed, and comfort care was provided. The patient died 12 hours later. In this patient, a second embolic event occurred within days of an embolic myocardial infarction despite therapeutic anticoagulation, and the CT findings at diagnosis already indicated non-salvageable bowel. The case illustrates why new abdominal symptoms in an anticoagulated patient with a recent cardioembolic event warrant immediate imaging and surgical assessment.
No takes yet. Share an insight, caveat, or question.
Rizon et al. (2026) conducted a case report in Atrial fibrillation with coronary embolism, left ventricular thrombus, and acute mesenteric ischemia (n=1). Enoxaparin, aspirin, and clopidogrel was evaluated on Recurrent systemic thromboembolism and survival.
Synapse has enriched 10 related papers. Consider them for comparative context: